EndometritisMANAGEMENT

INFECTIOUS DISEASE PRESENTATIONS · 12 SECTIONS

⚲

403 items

☷ Legend

01Approach to the Critical Patient/attcp38

First 5 minutes

›Instability triage

›Airway compromise

›Respiratory failure

›Shock

›Altered mental status

›Sepsis triggers

›Suspected uterine source

›Temperature ≥ 38.0 C

›Heart rate ≥ 110/min

›Respiratory rate ≥ 22/min

›Systolic blood pressure < 90 mmHg

›Immediate actions

›If shock, resuscitation bay

›Two large-bore IV

›Crystalloid 30 mL/kg for hypotension or lactate ≥ 4 mmol/L

›Norepinephrine if MAP < 65 mmHg after fluids

›If severe sepsis, time zero bundle

›Blood cultures before antibiotics if no delay

›Lactate within 1 hour

›Broad-spectrum IV antibiotics within 1 hour

›Source control pathways

›If retained products suspected, urgent obstetrics for evacuation planning

›If abscess suspected, gynecology and interventional radiology

›If necrotizing soft tissue infection, emergent surgical consult

Hemodynamic and monitoring targets

›Monitoring setup

›Continuous pulse oximetry

›Cardiac monitor

›Blood pressure cycling q5 min until stable

›Foley catheter if shock or strict urine output targets

›Targets

›MAP ≥ 65 mmHg

›Urine output ≥ 0.5 mL/kg/hour

›Lactate downtrend within 2 to 4 hours

Early consultations

›Team activation

›Obstetrics and gynecology early for postpartum or post-procedure cases

›ICU if vasopressors or rising lactate

›Infectious diseases if immunocompromised, bacteremia, or antibiotic complexity

›Anesthesia if urgent uterine evacuation and instability

02History/hx44

Presentation pattern

›Classic postpartum presentation

›Postpartum day 2 to 3 onset

›Fever

›Uterine fundal tenderness

›Foul-smelling lochia

›Non-postpartum presentation

›Post-procedure onset

›Post-abortion onset

›Postpartum day > 7 onset

Timing and risk context

›Delivery and procedure details

›Cesarean delivery

›Prolonged rupture of membranes

›Prolonged labor

›Multiple vaginal examinations

›Intraamniotic infection history

›Bleeding and retained tissue clues

›Heavy bleeding

›Passage of tissue

›Subinvolution symptoms

›Infectious exposure risks

›Group B streptococcus colonization status

›Recent antibiotics

›STI risks

›Postpartum urinary catheter

›Symptom review

›Pelvic pain

›Chills or rigors

›Malodorous discharge

›Dysuria or flank pain

›Breast pain or erythema

›Cough or dyspnea

›Wound pain or drainage

PITFALLS

›Atypical symptoms

›Minimal uterine tenderness with severe infection

›Afebrile presentation after antipyretics

›Missed alternate sources

›UTI or pyelonephritis

›Surgical site infection

›Mastitis

›Pneumonia

›Persistent fever despite antibiotics

›Septic pelvic thrombophlebitis

›Retained products

›Pelvic abscess

03Physical Exam/exam38

Focused vitals and general exam

›Systemic severity

›Toxic appearance

›Capillary refill delay

›Mottling

›Mental status changes

›Vitals pattern

›Fever trend

›Tachycardia out of proportion to fever

›Hypotension

›Tachypnea

Abdominal and pelvic exam

›Uterine exam

›Fundal tenderness

›Uterine size relative to postpartum day

›Subinvolution

›Lochia and discharge

›Foul odor

›Purulent discharge

›Excess bleeding

›Peritoneal signs

›Guarding

›Rebound tenderness

›Pelvic tenderness pattern

›Cervical motion tenderness

›Adnexal tenderness

›Pelvic mass concern

Extra-pelvic sources exam

›Breasts

›Focal erythema

›Fluctuance concern

›Surgical site

›Incision erythema

›Drainage

›Crepitus

›Lungs

›Focal crackles

›Hypoxia

›Legs

›Unilateral swelling

›Calf tenderness

04Differential Diagnosis/ddx27

Life-threatening and time-sensitive

›Critical diagnoses

›Postpartum endometritis (ICD-10 O86.12)

›Septic shock (ICD-10 R65.21)

›Necrotizing soft tissue infection of perineum (ICD-10 M72.6)

›Pelvic abscess

›Septic pelvic thrombophlebitis

›Hemorrhage-related

›Retained products of conception (ICD-10 O73.0)

›Secondary postpartum hemorrhage (ICD-10 O72.2)

Mimics and alternative sources of postpartum fever

›Genitourinary

›Cystitis

›Pyelonephritis

›Surgical and wound

›Cesarean wound infection

›Endometritis with uterine dehiscence concern

›Breast

›Mastitis

›Breast abscess

›Respiratory

›Pneumonia

›Aspiration pneumonitis

›Vascular

›DVT

›Pulmonary embolism

›Abdominal

›Appendicitis

›Cholecystitis

05Laboratory Tests/lt37

Sepsis and severity labs

›Initial panel

›Lactate

›Threshold ≥ 2 mmol/L for higher risk

›Threshold ≥ 4 mmol/L for aggressive resuscitation pathway

›Complete blood count

›Leukocytosis supportive but non-specific

›Leukopenia as severe sepsis marker

›Electrolytes and creatinine

›Acute kidney injury support for ICU triage

›Liver enzymes

›Sepsis-associated organ dysfunction marker

›Perfusion and coagulopathy

›Venous blood gas

›Acidemia support for severity

›INR and aPTT

›DIC screening if shock or bleeding

›Fibrinogen

›Low value supportive of DIC

›Platelets

›Thrombocytopenia supportive of severe sepsis

Microbiology

›Cultures

›Blood cultures x2

›Prior to antibiotics if no delay

›Urine culture

›Pyelonephritis mimic exclusion

›Endocervical or vaginal NAAT if STI concern

›Chlamydia

›Gonorrhea

›When available

›Uterine cultures

›Typically not required for initial therapy

›Consider if ICU course or treatment failure

Other targeted labs

›Pregnancy-related

›Beta-hCG if postpartum status uncertain

›Bleeding concern

›Type and screen

›Hemoglobin trend

06Diagnostic Tests/dt48

Scoring Systems

›Severity tools

›qSOFA

›Respiratory rate ≥ 22/min

›Altered mentation

›Systolic blood pressure ≤ 100 mmHg

›SOFA

›Respiratory component

›Coagulation component

›Liver component

›Cardiovascular component

›CNS component

›Renal component

›Obstetric sepsis screen triggers

›Persistent tachycardia

›Hypotension

›Rising lactate

›Oliguria

MRI

›Indications

›Pelvic deep infection concern with CT contraindication

›Complex adnexal pathology characterization

›Limitations

›Delay to imaging in unstable patient

›Limited availability off-hours

›Indications

›Persistent fever > 48 to 72 hours on appropriate antibiotics

›Pelvic abscess concern

›Septic pelvic thrombophlebitis concern

›Alternative intraabdominal source concern

›Technique considerations

›Contrast CT abdomen and pelvis if renal function allows

›Venous phase adequacy for pelvic thrombosis assessment

›Interpretation pearls

›Rim-enhancing fluid collection for abscess

›Enlarged ovarian vein with thrombus for ovarian vein thrombosis

›Evidence level

›CT for abscess localization and drainage planning (ACEP Level C)

Ultrasound

›Pelvic ultrasound use cases

›Retained products of conception concern

›Endometrial thickening supportive but non-specific

›Intrauterine echogenic material

›Increased vascularity on Doppler supportive

›Hematometra or intrauterine fluid collection

›Adnexal mass or tubo-ovarian abscess concern

›POCUS pathways

›If shock, focused cardiac ultrasound for pericardial effusion

›If shock, IVC assessment for volume responsiveness adjunct

›Evidence level

›Ultrasound for retained products evaluation (ACEP Level C)

07Disposition/dispo22

Level of care decisions

›Admission indications

›Postpartum endometritis suspected

›IV antibiotics required

›Inability to tolerate oral intake

›Significant pain requiring parenteral therapy

›ICU indications

›Vasopressors requirement

›Lactate ≥ 4 mmol/L

›Multi-organ dysfunction

›Persistent hypotension

›Altered mental status

›Transfer criteria

›Need for obstetric surgical capability not available

›Need for interventional radiology drainage not available

Discharge pathways

›Limited outpatient scenarios

›Mild non-postpartum endometritis with reliable follow-up

›No sepsis physiology

›Oral antibiotic plan in place

›Safety prerequisites

›Reassessment after initial management

›Clear return precautions

›Follow-up within 24 to 48 hours if outpatient

08Treatment/t60

Empiric antibiotics

›First-line postpartum regimen

›Clindamycin plus gentamicin

›Clindamycin IV 900 mg q8h

›Anaerobe coverage

›Toxin suppression benefit in streptococcal infection concern

›Gentamicin IV 5 mg/kg q24h

›Adjusted body weight if obesity

›Trough monitoring per local protocol if prolonged course

›Continue until afebrile 24 to 48 hours

›No routine oral step-down required after clinical response

›Enterococcus coverage triggers

›If no improvement by 48 hours, add ampicillin

›Ampicillin IV 2 g q6h

›Enterococcus coverage

›If known GBS colonization with clindamycin resistance concern, add ampicillin

›Alternative single-agent IV regimens

›Ampicillin-sulbactam IV 3 g q6h

›Broad aerobic and anaerobic coverage

›Useful if aminoglycoside avoidance

›Piperacillin-tazobactam IV 4.5 g q8h

›If severe sepsis or polymicrobial concern

›If persistent fever after first-line regimen

›Ertapenem IV 1 g q24h

›If beta-lactamase risk and stable hemodynamics

›Avoid if Pseudomonas concern

Sepsis resuscitation and supportive care

›Fluids and pressors

›Crystalloid bolus strategy

›500 to 1000 mL reassessment cycles if not meeting 30 mL/kg pathway

›Lung ultrasound for fluid tolerance adjunct

›Norepinephrine infusion

›Initiate if MAP < 65 mmHg after fluids

›Titrate q2 to 5 minutes to MAP target

›Antipyresis and analgesia

›Acetaminophen

›Max daily dose per local protocol

›NSAIDs if no renal injury or bleeding concern

›Thromboprophylaxis

›Pharmacologic VTE prophylaxis during admission if no contraindications

›Mechanical prophylaxis if bleeding risk

Source control

›Retained products pathway

›If ultrasound supports retained products with ongoing bleeding, obstetrics evacuation planning

›If hemodynamic instability with hemorrhage, emergent uterine evacuation pathway

›Abscess pathway

›If imaging confirms abscess, drainage planning

›Interventional radiology percutaneous drainage

›Operative drainage if percutaneous not feasible

›Necrotizing infection pathway

›If perineal crepitus or rapid progression, emergent debridement

›Broad necrotizing coverage regimen per sepsis protocol

Treatment failure and escalation

›Persistent fever > 48 to 72 hours on appropriate antibiotics

›CT abdomen and pelvis for abscess or thrombophlebitis

›Antibiotic broadening pathway

›Switch to piperacillin-tazobactam

›Consider carbapenem if resistant organism concern

›Septic pelvic thrombophlebitis suspicion

›Persistent fevers with negative imaging for abscess

›Anticoagulation consideration with obstetrics and hematology

›Continue antibiotics during anticoagulation course

Evidence levels and outcomes

›Clindamycin plus gentamicin as effective first-line regimen for postpartum endometritis (ACEP Level C)

›Once-daily gentamicin dosing similar clinical success to q8h dosing in postpartum endometritis (ACEP Level C)

09Special Populations/sp24

Pregnancy

›Postpartum physiology considerations

›Normal postpartum leukocytosis as diagnostic confounder

›Hypercoagulability postpartum with thrombosis risk

›Lactation considerations

›Clindamycin compatible with breastfeeding

›Gentamicin minimal oral absorption in infant

›Monitor infant for diarrhea or thrush if maternal antibiotics

›Obstetric complications overlap

›Retained products association with secondary hemorrhage

›Endometritis risk higher after cesarean delivery

Geriatric

›Post-procedure endometritis considerations

›Higher comorbidity burden

›Higher risk of rapid decompensation

›Medication considerations

›Renal dosing for aminoglycosides

›Drug interactions with anticoagulants

Pediatrics

›Adolescent endometritis context

›STI-associated endometritis within PID spectrum

›Mandatory pregnancy testing in reproductive-age adolescents

›Antibiotic selection

›PID regimens per local and national STI guidance

›Weight-based dosing for all agents

›Safeguarding considerations

›Sexual assault and consent context pathways as indicated

10Background/b32

Epidemiology

›Incidence patterns

›Higher rates after cesarean delivery than after vaginal delivery

›Polymicrobial infection as typical postpartum pattern

›Risk factors prevalence contributors

›Prolonged rupture of membranes

›Prolonged labor

›Multiple vaginal examinations

›Intraamniotic infection

Pathophysiology

›Mechanism

›Ascending polymicrobial infection of decidua and endometrium

›Anaerobes and aerobes synergy

›Common organisms

›Anaerobes

›Bacteroides species

›Peptostreptococcus

›Aerobes

›Streptococcus species

›Enterococcus species

›Enterobacterales

›Complications

›Bacteremia

›Pelvic abscess

›Septic pelvic thrombophlebitis

›Septic shock

Therapeutic Considerations

›Antibiotic rationale

›Broad anaerobic plus gram-negative coverage requirement postpartum

›Enterococcus coverage as escalation consideration

›Duration rationale

›Clinical response based discontinuation after afebrile 24 to 48 hours

›Prevention concepts

›Cesarean prophylactic antibiotics reduce endometritis risk

›Avoid unnecessary vaginal examinations after membrane rupture

11Patient Discharge Instructions/pdi19

copy discharge instructions

›Home care

›Rest

›Hydration

›Continue prescribed antibiotics exactly as directed if outpatient regimen

›Return now

›Fever

›Worsening pelvic or abdominal pain

›Heavy bleeding

›Fainting

›New shortness of breath

›Chest pain

›Confusion

›Persistent vomiting

›Follow-up

›Obstetrics or gynecology follow-up within 24 to 72 hours

›Earlier follow-up if symptoms not improving within 24 hours

›Breastfeeding

›Continue breastfeeding unless clinician advises otherwise

›Infant diarrhea or oral thrush monitoring

12References/r14

Clinical guidelines and evidence

›Merck Manual Professional Edition

›Postpartum endometritis treatment section

›Clindamycin 900 mg IV q8h plus gentamicin as first-line regimen

›Cochrane review

›Antibiotic regimens for postpartum endometritis

›Clindamycin plus gentamicin more effective than many alternatives

›NIH NCBI Bookshelf StatPearls

›Postpartum infection and endometritis treatment summaries

›Continue IV therapy until afebrile for 24 to 48 hours

›American Journal of Obstetrics and Gynecology

›Once-daily gentamicin dosing efficacy compared with q8h dosing in postpartum endometritis

›CDC STI Treatment Guidelines

›PID spectrum includes endometritis

›STI-associated upper genital tract infection considerations

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed June 16, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.